Department of Gynecology, Shaanxi Nuclear Industry 215 Hospital, Xianyang, Shaanxi, P.R. China.
Department of Endoscopy, Shaanxi Nuclear Industry 215 Hospital, Xianyang, Shaanxi, P.R. China.
Oncol Res. 2018 Jun 11;26(5):713-723. doi: 10.3727/096504017X15016337254641. Epub 2017 Aug 11.
MicroRNAs (miRNAs) are small noncoding RNAs that are involved in human carcinogenesis and progression. miR-204 has been reported to be a tumor suppressor in several cancer types. However, the function and underlying molecular mechanism of miR-204 in cervical cancer (CC) are still unclear. In the present study, the expression level of miR-204 was measured using the qRT-PCR method in 30 paired CC clinical samples and in 6 CC cell lines. We found that the expression of miR-204 was significantly downregulated in CC tissues and cell lines compared to normal cervical tissues and cell line. miR-204 was overexpressed by transfection with the miR-204 mimic in HeLa and C33A cell lines in the following experiments. The results showed that overexpression of miR-204 dramatically suppressed cell proliferation, migration, and invasion, caused cell cycle arrest at the G0/G1 phase, promoted cell apoptosis in vitro, and inhibited tumor growth in vivo. Western blot results indicated that overexpressing miR-204 decreased the expressions of CDK2, cyclin E, MMP2, MMP9, Bcl2, whereas it enhanced Bax expression and suppressed the activation of the PI3K/AKT signaling pathways in CC cells. Ephrin type B receptor 2 (EphB2) was identified as a direct target of miR-204 in CC cells according to bioinformatics analysis and luciferase reporter assay. Furthermore, knockdown of EphB2 mimicked the inhibitory effect of miR-204 on the proliferation, invasion, and migration of CC cells. These findings suggested that miR-204 might serve as a tumor suppressor in the development of CC by directly targeting EphB2.
微小 RNA(miRNAs)是参与人类致癌和进展的小非编码 RNA。已经报道 miR-204 在几种癌症类型中是一种肿瘤抑制因子。然而,miR-204 在宫颈癌(CC)中的功能和潜在分子机制仍不清楚。在本研究中,使用 qRT-PCR 方法测量了 30 对 CC 临床样本和 6 种 CC 细胞系中 miR-204 的表达水平。我们发现,与正常宫颈组织和细胞系相比,CC 组织和细胞系中 miR-204 的表达显著下调。在后续实验中,通过转染 miR-204 模拟物使 miR-204 在 HeLa 和 C33A 细胞系中过表达。结果表明,miR-204 的过表达显著抑制细胞增殖、迁移和侵袭,导致细胞周期停滞在 G0/G1 期,促进体外细胞凋亡,并抑制体内肿瘤生长。Western blot 结果表明,过表达 miR-204 降低了 CDK2、cyclin E、MMP2、MMP9、Bcl2 的表达,而增强了 Bax 的表达并抑制了 CC 细胞中 PI3K/AKT 信号通路的激活。根据生物信息学分析和荧光素酶报告基因检测,Ephrin 型 B 受体 2(EphB2)被鉴定为 CC 细胞中 miR-204 的直接靶标。此外,EphB2 的敲低模拟了 miR-204 对 CC 细胞增殖、侵袭和迁移的抑制作用。这些发现表明,miR-204 可能通过直接靶向 EphB2 作为肿瘤抑制因子在 CC 的发展中发挥作用。